Live Breaking News & Updates on Elderly Relapsed

Stay updated with breaking news from Elderly relapsed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering. ....

United States , Salt Lake City , Salt Palace Convention Center , Hans Vitzthum , Boglarka Gyurkocza , Sandesh Seth , James Foran , Avinash Desai , Lifesci Advisors , University Of Texas Md Anderson Cancer Center , American Society For Transplantation , International Blood Marrow Transplant Research , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , European Medicines Agency , Committee For Medicinal Products Human Use , Epicentrx Inc , Fred Hutchinson Cancer Research Center , Mayo Clinical Cancer Center , Memorial Sloan Kettering Cancer Center , Memorial Sloan Kettering Cancer , Patient Journey , Applying Evidence , Novel Therapeutics , Actinium Pharmaceuticals ,

Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and North Africa

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies for. ....

United States , Sandesh Seth , Hans Vitzthum , Anders Edvell , Lifesci Advisors , Shadow Lake Group , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , European Medicines Agency , Committee For Medicinal Products Human Use , Epicentrx Inc , Memorial Sloan Kettering Cancer Center , Fred Hutchinson Cancer Research Center , Middle East , Actinium Pharmaceuticals , Immedica Pharma , Antibody Radiation Conjugate , Conventional Care , Refractory Acute Myeloid Leukemia , North Africa , Lake Group , Acute Myeloid Leukemia , Orphan Drug Designation , Scientific Advice , Medicinal Products ,

Actinium Pharmaceuticals, Inc. and EpicentRx Announce Strategic Research Collaboration to Combine Targeted Radiotherapies with Next Generation CD47/SIRPα Immunotherapy

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Astellas Pharma , Epicentrx Cy , Epicentrx Rrx , Tonyr Reid , Sandesh Seth , Hans Vitzthum , Lifesci Advisors , Taft Communications , Society For Immunotherapy Of Cancer , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Epicentrx Inc , Memorial Sloan Kettering Cancer Center , Prnewswire Actinium Pharmaceuticals Inc , San Diego Based , Small Cell Lung Cancer , Annual Society , Antibody Radiation Conjugates , Chief Executive Officer , Actinium Pharmaceuticals , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy , Elderly Relapsed , Refractory Acute Myeloid Leukemia ,

Actinium Pharmaceuticals, Inc. and EpicentRx Announce Strategic Research Collaboration to Combine Targeted Radiotherapies with Next Generation CD47/SIRPα Immunotherapy

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Astellas Pharma , Epicentrx Cy , Epicentrx Rrx , Tonyr Reid , Sandesh Seth , Hans Vitzthum , Lifesci Advisors , Taft Communications , Society For Immunotherapy Of Cancer , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Epicentrx Inc , Memorial Sloan Kettering Cancer Center , Prnewswire Actinium Pharmaceuticals Inc , San Diego Based , Small Cell Lung Cancer , Annual Society , Antibody Radiation Conjugates , Chief Executive Officer , Actinium Pharmaceuticals , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy , Elderly Relapsed , Refractory Acute Myeloid Leukemia ,

Actinium Pharmaceuticals, Inc. Announces Participation in Two Panel Discussions at the 3rd Targeted Radiopharmaceuticals Summit

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Hans Vitzthum , Mary Chen , Helen Kotanides , Preclinical Development , Lifesci Advisors , Exchange Commission , Months Of Development Alpha Emitting Therapies , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Translational Research , Clinical Development , Memorial Sloan Kettering Cancer Center , Actinium Pharmaceuticals , Targeted Radiopharmaceuticals Summit , Targeted Radiopharmaceuticals , Alpha Emitting Therapies , Next Generation Alpha Emitter Based , Expert Speaker , Vice President , High Dose , Low Dose Therapeutic Strategy , Optimizing Treatment , Antibody Radiation Conjugates , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy ,